MedPage Today on MSN
Novel pills promising in relapsed/refractory multiple myeloma
In a 2024 review, Richardson and colleagues noted that the immunomodulatory drugs thalidomide, lenalidomide (Revlimid), and ...
Please provide your email address to receive an email when new articles are posted on . It is a truism that, “If you operate, you will have complications.” Wise surgeons plan ahead to avoid ...
Leyla O. Shune, MD, describes the available treatment options for patients with chronic graft-versus-host disease who are ...
In this study, researchers aimed to determine whether patients with standard-risk relapsed/refractory multiple myeloma had improved survival with earlier-line cilta-cel therapy.
Refractory angina is an increasingly prevalent clinical syndrome characterized by ongoing ischaemic symptoms despite optimal medical management in patients for whom traditional revascularization is ...
Andrew Yee, MD, introduces the discussion by reviewing treatment challenges, patient education, and decision-making in ...
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for ...
Cancer Research UK's Centre for Drug Development is sponsoring and conducting the phase I/II clinical trial of ALETA-001, the lead agent in Aleta Biotherapeutics' portfolio. Additional clinical trial ...
Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using ...
Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or its treatments may contribute to ocular surface disease. In this Q&A ...
Please provide your email address to receive an email when new articles are posted on . Case history: A 72-year-old patient underwent cataract surgery using the Crystalens accommodating lens implant ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- WaveTec Vision, the leader in wavefront-guided custom cataract™ surgery, announced today that its ORange ® intraoperative wavefront aberrometer has been shown to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results